Over the counter NSAIDs have consistently shown antitumor effects in animal models of carcinogenesis [16], and striking antitumor effects of the specific COX-2 inhibitor, celecoxib, have been observed against colon cancer [17]. This evidence concerns the gene PTGS2 and colonic neoplasm.